PRPF8 and central nervous system cancer: To test this hypothesis, we transfected glioma cells with the miR-10b antisense oligonucleotide (ASO) inhibitor and examined the effects of miR-10b KD on the U6 association with SART3 and PRPF8 using iCLIP.